Univest Financial’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-2,472
Closed -$215K – 269
2025
Q2
$215K Buy
2,472
+90
+4% +$7.63K 0.01% 250
2025
Q1
$214K Buy
+2,382
New +$213K 0.01% 262
2024
Q4
– Sell
-2,778
Closed -$250K – 286
2024
Q3
$250K Buy
+2,778
New +$234K 0.02% 252
2023
Q3
– Sell
-3,049
Closed -$269K – 114
2023
Q2
$269K Buy
3,049
+544
+22% +$46.8K 0.08% 91
2023
Q1
$202K Buy
+2,505
New +$204K 0.06% 103
2022
Q2
– Sell
-1,809
Closed -$201K – 110
2022
Q1
$201K Buy
+1,809
New +$191K 0.06% 113
2021
Q4
– Sell
-1,872
Closed -$235K – 115
2021
Q3
$235K Sell
1,872
-719
-28% -$93.1K 0.07% 101
2021
Q2
$322K Buy
2,591
+500
+24% +$62.8K 0.09% 91
2021
Q1
$247K Buy
2,091
+126
+6% +$14.8K 0.07% 99
2020
Q4
$230K Sell
1,965
-492
-20% -$54.2K 0.07% 100
2020
Q3
$255K Sell
2,457
-68
-3% -$6.83K 0.08% 92
2020
Q2
$232K Buy
2,525
+13
+0.5% +$1.25K 0.08% 94
2020
Q1
$227K Buy
+2,512
New +$267K 0.09% 102

Other funds holding MDT

Univest Financial's MDT Position: Q3 2025 in Review

Univest Financial sold out of Medtronic (MDT) in Q3 2025, closing a stake of 2,472 shares — an estimated $215K sold.

Univest Financial first reported a position in MDT in Q1 2020 and held it in 13 quarters. The position peaked at $322K in Q2 2021. 2,177 funds tracked by Wall St. Rank hold MDT as of Q3 2025.

  • Univest Financial reported no remaining Medtronic position as of Q3 2025 after selling out during the quarter.
  • Univest Financial sold 2,472 Medtronic shares in Q3 2025, an estimated $215K.
  • Univest Financial first reported a position in Medtronic in Q1 2020 and held it in 13 quarters.
  • Univest Financial's Medtronic position peaked at $322K in Q2 2021.
  • 2,177 funds tracked by Wall St. Rank held Medtronic as of Q3 2025.

Based on Univest Financial's 13F filing for Q3 2025, filed 30 Oct 2025.